I upgrade JD Health to a Buy due to market share growth, favorable policies, and a strong balance sheet. JDHIY's sales are projected to rise by 12% this year, driven by online market expansion and the broadening of insurance reimbursement coverage. JD Health's operating margin is expected to improve, benefiting from fixed-cost leverage and new offerings.